GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a major focus in medical investigation, largely due to its notable impact on managing diseases such as second type diabetes and excess body fat. Recent trials have shown that more than glucose control, GLP-1 drugs offer potential for circulatory well-being and even cogn